Showing 1 - 10 of 14
Persistent link: https://www.econbiz.de/10014564283
European COvid Survey (ECOS), a longitudinal study spanning eight European countries, was initiated early in the COVID-19 pandemic. Its purpose was to comprehend public perceptions, trust, knowledge, and behaviors related to COVID-19, including vaccination. The study aimed to enable timely...
Persistent link: https://www.econbiz.de/10014481219
In der öffentlichen Diskussion um die Einführung einer Bürgerversicherung zur Reform der Finanzierung der Gesetzlichen Krankenversicherung werden häufiger Modelle mit Kopfpauschalen oder Kopfprämien diskutiert. Dabei sind verschiedene Herangehensweisen bei der Ermittlung der Höhe der...
Persistent link: https://www.econbiz.de/10010300522
In der öffentlichen Diskussion um die Einführung einer Bürgerversicherung zur Reform der Finanzierung der Gesetzlichen Krankenversicherung werden häufiger Modelle mit Kopfpauschalen oder Kopfprämien diskutiert. Dabei sind verschiedene Herangehensweisen bei der Ermittlung der Höhe der...
Persistent link: https://www.econbiz.de/10009492628
Persistent link: https://www.econbiz.de/10002402025
Persistent link: https://www.econbiz.de/10002023434
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...
Persistent link: https://www.econbiz.de/10010300533
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this health...
Persistent link: https://www.econbiz.de/10003726009
Persistent link: https://www.econbiz.de/10003978870
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...
Persistent link: https://www.econbiz.de/10009492625